Literature DB >> 3260131

An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells.

P L Tazzari1, L Barbieri, M Gobbi, A Dinota, S Rizzi, A Bontadini, A Pession, S Tura, F Stirpe.   

Abstract

The elimination of the cells responsible for graft-versus-host disease in allogeneic bone marrow transplantation has been attempted with a variety of methods, including the use of the ribosome-inactivating toxin ricin bound to monoclonal antibodies acting as carriers. However the high nonspecific toxicity of these immunotoxins containing the whole toxin greatly limited clinical application. Toxicity can be reduced using the A-chain of ricin or other ribosome-inactivating proteins (RIPs) which are devoid of a B-chain with lectin properties. We used saporin 6 purified from Saponaria officinalis seeds, which was conjugated with the rat IgM monoclonal antibody Campath 1 specific for mature T and B lymphocytes as well as for monocytes. The immunotoxin retained both RIP and antibody activity, inhibiting protein synthesis both in a cell-free system and in cells bearing the Campath 1 antigen; it also abolished methyl 3H-thymidine uptake in phytohemagglutinin-stimulated T lymphocytes. Myeloid progenitors were largely spared as shown by myeloid stem cell (CFU-GM) growth which was scarcely affected. Toxicity of the immunotoxin to cell lines not expressing the antigen recognized by Campath 1 monoclonal antibody was not greater than the toxicity due to free saporin 6, while the immunotoxin was more toxic to mice than free saporin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260131     DOI: 10.1007/bf00199934

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  44 in total

1.  Application of magnetic microspheres in labelling and separation of cells.

Authors:  R S Molday; S P Yen; A Rembaum
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

2.  Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.

Authors:  M Bregni; P De Fabritiis; V Raso; J Greenberger; J Lipton; L Nadler; L Rothstein; J Ritz; R C Bast
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

Review 3.  Ribosome-inactivating proteins up to date.

Authors:  F Stirpe; L Barbieri
Journal:  FEBS Lett       Date:  1986-01-20       Impact factor: 4.124

4.  Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from blood.

Authors:  S Ramakrishnan; L L Houston
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

5.  Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells.

Authors:  K Eiklid; S Olsnes; A Pihl
Journal:  Exp Cell Res       Date:  1980-04       Impact factor: 3.905

6.  Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.

Authors:  S Ramakrishnan; L L Houston
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

7.  Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis.

Authors:  F Stirpe; M Derenzini; L Barbieri; F Farabegoli; A N Brown; P P Knowles; P E Thorpe
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1987

8.  Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption.

Authors:  R J Berenson; W I Bensinger; D Kalamasz; P Martin
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

9.  Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin.

Authors:  P E Thorpe; A N Brown; W C Ross; A J Cumber; S I Detre; D C Edwards; A J Davies; F Stirpe
Journal:  Eur J Biochem       Date:  1981-06-01

10.  An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.

Authors:  P E Thorpe; A N Brown; J A Bremner; B M Foxwell; F Stirpe
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

View more
  4 in total

Review 1.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 2.  Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research.

Authors:  Andrea Bolognesi; Massimo Bortolotti; Maria Giulia Battelli; Letizia Polito
Journal:  Molecules       Date:  2017-01-27       Impact factor: 4.411

3.  Recognition and killing of tumour cells expressing heat shock protein 65 kD with immunotoxins containing saporin.

Authors:  F Poccia; P Piselli; S Di Cesare; S Bach; V Colizzi; M Mattei; A Bolognesi; F Stirpe
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

4.  Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation.

Authors:  P L Tazzari; S Zhang; Q Chen; S Sforzini; A Bolognesi; F Stirpe; H Xie; A Moretta; S Ferrini
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.